BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20526106)

  • 1. Novel agents in the treatment of metastatic colorectal cancer.
    Leong S; Messersmith WA; Tan AC; Eckhardt SG
    Cancer J; 2010; 16(3):273-82. PubMed ID: 20526106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapy.
    Serrano C; Markman B; Tabernero J
    Cancer J; 2010; 16(3):226-34. PubMed ID: 20526101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel targeted agents in the treatment of metastatic colorectal cancer.
    Berge E; Thompson C; Messersmith W
    Clin Colorectal Cancer; 2011 Dec; 10(4):266-78. PubMed ID: 21903484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
    Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
    J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment of metastatic colorectal cancer.
    Pessino A; Sobrero A
    Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising targets and drugs in development for colorectal cancer.
    Thompson C; Leong S; Messersmith W
    Semin Oncol; 2011 Aug; 38(4):588-97. PubMed ID: 21810518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics and -genetics in colorectal cancer.
    Pohl A; Lurje G; Manegold PC; Lenz HJ
    Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future.
    Marshall JL; Gehan EA
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):167-72. PubMed ID: 17519876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.
    O'Neil BH; Goldberg RM
    Expert Opin Investig Drugs; 2003 Dec; 12(12):1939-49. PubMed ID: 14640938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy for colorectal cancer.
    Hwang J; Marshall JL
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1062-6. PubMed ID: 17209523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular therapy of colorectal cancer.
    Waldner MJ; Neurath MF
    Mol Aspects Med; 2010 Apr; 31(2):171-8. PubMed ID: 20171980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on new chemotherapeutic agents in the treatment of colorectal cancer.
    Clark JW
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-19-S18-24. PubMed ID: 9420017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic colorectal cancer.
    Saletti P; Cavalli F
    Cancer Treat Rev; 2006 Nov; 32(7):557-71. PubMed ID: 16935430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.